Compare HubSpot Inc (HUBS) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HubSpot Inc vs Novavax Inc — how do they compare? HubSpot Inc trades at $217.27 (market cap $11.84B), while Novavax Inc trades at $7.9 (market cap $1.30B). The key difference: HubSpot Inc is far larger — about 9.1× Novavax Inc's market cap, and Novavax Inc is trading nearer its 52-week high, HubSpot Inc nearer its low. Which is the better fit depends on your goals.
| HUBS | NVAX | |
|---|---|---|
Market Cap | $11.84B | $1.30B |
Sector | Technology | Health |
52-Week High | $560.90 | $11.19 |
52-Week Low | $170.39 | $6.22 |
Enterprise Value | $10.39B | $800.50M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About HubSpot Inc
HubSpot provides a cloud-based marketing, sales, and customer service software platform referred to as the growth platform. The applications are available ala carte or packaged together. HubSpot's mission is to help companies grow better and has expanded from its initial focus on inbound marketing to embrace marketing, sales, and service more broadly. The company was founded in 2006, completed its initial public offering in 2014, and is headquartered in Cambridge, Massachusetts.
Read more on HUBS →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
